Sign in

NCT06363253Recruiting

Pilot Study of the Human Metagenome in Metabolic Diseases

Understanding the Role of the Human Metagenome in Obesity, Metabolic Diseases, Chronic Inflammation, Sarcopenia and Sarcopenic Obesity - a Pilot Study

Source: ClinicalTrials.gov · Last updated 15 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a cohort study to understand the role of the human metagenome, and associated metabolites, in health and in various diseased states, in particular obesity as well as sarcopenia. Recruited participants will have their fecal, salivary, urine, serum, and in certain instances, mucosal samples taken, for metagenomic sequencing and metabolite testing. We hope to uncover various differences and signatures in the metagenome and metabolome in various diseased states, with potential future therapeutic applications in personalised medicine.

Status (registry)
Recruiting
Study type
Observational
Enrollment
600 (estimated)
First submitted
9 Apr 2024
Start date
14 Aug 2023
Primary completion date
31 Dec 2026
Lead sponsor
Sengkang General Hospital
Diseases
Obesity
NCT number
NCT06363253

What you commit to

  • Study type: Observational
  • Planned participants: 600
  • From 14 Aug 2023 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • No informed consent
  • Presence of intestinal stoma, hence inability to collect fecal samples

Who the study is looking for

  • Obese (BMI\>27.5kg/m2)
  • Sarcopenic patients, defined as 1) low handgrip strength (\<26 for males; \<18kg for females), AND/OR low gait speed (\<0.8m/s) AND low muscle mass (\<7.0kg/m2 for males; \<5.7kg/m2 for females)
  • \- Healthy subjects without sarcopenia, and not obese (BMI\<27.5kg/m2)

Age in the registry: 21 years to 99 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Sengkang General Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.